Page last updated: 2024-08-23

torpedo and isoxazoles

torpedo has been researched along with isoxazoles in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apostolski, S; Bartlett, RR; Damjanovic, M; Isakovic, K; Kosec, D; Vidic-Dankovic, B	1
Cohen, JB; Deba, F; Hamouda, AK; Wang, ZJ	1

Other Studies

2 other study(ies) available for torpedo and isoxazoles

Article	Year
Leflunomide prevents the development of experimentally induced myasthenia gravis. International journal of immunopharmacology, 1995, Volume: 17, Issue:4 Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Flow Cytometry; Immunization; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myasthenia Gravis; Rats; Rats, Inbred Strains; Receptors, Cholinergic; T-Lymphocyte Subsets; Thymus Gland; Time Factors; Torpedo	1995
Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator. Molecular pharmacology, 2016, Volume: 89, Issue:5 Topics: Allosteric Regulation; Animals; Binding Sites; Humans; Isoxazoles; Kinetics; Models, Molecular; Muscle Proteins; Nerve Tissue Proteins; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Patch-Clamp Techniques; Photolysis; Protein Conformation; Protein Isoforms; Protein Subunits; Pyrazoles; Radioligand Assay; Receptors, Nicotinic; Recombinant Proteins; Torpedo; Xenopus laevis	2016

Article

Year

Leflunomide prevents the development of experimentally induced myasthenia gravis.

International journal of immunopharmacology, 1995, Volume: 17, Issue:4

Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Flow Cytometry; Immunization; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myasthenia Gravis; Rats; Rats, Inbred Strains; Receptors, Cholinergic; T-Lymphocyte Subsets; Thymus Gland; Time Factors; Torpedo

1995

Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.

Molecular pharmacology, 2016, Volume: 89, Issue:5

Topics: Allosteric Regulation; Animals; Binding Sites; Humans; Isoxazoles; Kinetics; Models, Molecular; Muscle Proteins; Nerve Tissue Proteins; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Patch-Clamp Techniques; Photolysis; Protein Conformation; Protein Isoforms; Protein Subunits; Pyrazoles; Radioligand Assay; Receptors, Nicotinic; Recombinant Proteins; Torpedo; Xenopus laevis

2016